FDA to Phase Out Animal Testing for Monoclonal Antibodies and other Drugs
By EsqSocial Corporation 16/04/25
On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced it will be phasing out the current requirements for animal testing in the development of monoclonal antibody therapies and other drugs, replacing them “with more effective, human-relevant methods.”...
By: Goodwin